DPIIT recognised startup Government of India
Startup India
Dikora Bulk Drug Private Limited - chemicals and materials in Bhusawal, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.1 Cr
▼ 48% YoY
Net profit · FY 2025
₹2.18 Lakh
Net margin 1%
EBITDA · FY 2025
₹83.71 Lakh
EBITDA margin 39.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹2.58 Cr
Satisfied ₹3.88 Cr
Company age
9 yrs
Est. 2017
Directors on board
5
As per MCA filings
About Dikora Bulk Drug Private Limited
Data last updated:
Dikora Bulk Drug Private Limited is a private limited company based in Bhusawal, Maharashtra, India, recognised as a startup by DPIIT. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 28 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2017PTC303432. Its GSTIN is 27AAGCD4926K1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Dineshkumar Purushottam Patel and Komal Vikram Patil.
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 29 MIDC Area Bhuswal, Bhusawal, Maharashtra, India – 425201.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net profit of ₹2.18 Lakh (net margin 1%) and EBITDA of ₹83.71 Lakh (EBITDA margin 39.8%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years and 24% over five years.
As per MCA filings, the company has open charges of ₹2.58 Cr and satisfied charges of ₹3.88 Cr on record.
Dikora Bulk Drug Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-14-0019040). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dikorabulkdrug.com.
Company details
CIN U24100MH2017PTC303432
Registration Number 303432
Incorporation Date 28 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 09 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-14-0019040
Key People
Dineshkumar Purushottam Patel Director Komal Vikram Patil Director Rohit Dinesh Patel Director Recognitions & Rankings of Dikora Bulk Drug
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-14-0019040
Contact details
Dikora Bulk Drug Private Limited's registered office is in Bhusawal, Maharashtra. Its website is dikorabulkdrug.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 29 MIDC Area Bhuswal, Bhusawal, Maharashtra, India – 425201
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Dikora Bulk Drug Private Limited, buy the company report.
Comprehensive company report
Dikora Bulk Drug Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dikora Bulk Drug is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dikora Bulk Drug Private Limited, buy the company report.
Financials of Dikora Bulk Drug Private Limited
FY 2025 filings availableDikora Bulk Drug Private Limited reported revenue of ₹2.1 Cr (down 48% YoY) for FY 2025.
Revenue · FY 2025
₹2.1 Cr ▼ 48%
Net profit · FY 2025
₹2.18 Lakh margin 1%
EBITDA · FY 2025
₹83.71 Lakh margin 39.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 32%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 18%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 48% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 39.8% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dikora Bulk Drug Private Limited, buy the company report.
Board of directors of Dikora Bulk Drug Private Limited
Dikora Bulk Drug has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dineshkumar Purushottam Patel | Director | 28 Dec 2017 | 8 Years 10 Months | Current |
| Komal Vikram Patil | Director | 28 Dec 2017 | 8 Years 10 Months | Current |
| Rohit Dinesh Patel | Director | 28 Dec 2017 | 8 Years 10 Months | Current |
| Pratik Dinesh Patel | Director | 28 Dec 2017 | 8 Years 10 Months | Current |
| Yogesh Purushottam Patel | Director | 28 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
Dikora Bulk Drug Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mirth Capital and Finlease Limited | ₹2.12 Cr (FY 2025) | 79.0% | New Delhi, Delhi, India | |||
| Chemosol Industries (India) Private Limited | ₹2.11 Cr (FY 2024) | -59.0% | Mumbai, Maharashtra, India | |||
| Dikora Bulk Drug Private Limitedthis company | ₹2.1 Cr (FY 2025) | ₹2.18 Lakh | 1% | -48.0% | Bhusawal, Maharashtra, India | |
| Omicron Pharma Private Limited | ₹2.1 Cr (FY 2025) | -3.0% | Surat, Gujarat, India | |||
| Anika Cards N Crafts Private Limited | ₹2.1 Cr (FY 2025) | 4.0% | Faridabad, Haryana, India | |||
| Enzosynth Private Limited | ₹2.1 Cr (FY 2025) | -9.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Dikora Bulk Drug Private Limited, buy the company report.
Auditor
Dikora Bulk Drug Private Limited is audited by R S KABRA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S KABRA & CO | FY 2020 | 104505W |
Shareholding
The shareholding of Dikora Bulk Drug Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Dikora Bulk Drug Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.58 Cr
Satisfied charges
₹3.88 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Oct 2024 | 101009720 | Hdfc Bank Limited | ₹2.58 Cr | Open | |
| 04 Dec 2018 | 100225527 | State Bank of India | ₹3.88 Cr | Satisfied |
To see the full charge records of Dikora Bulk Drug Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Dikora Bulk Drug Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dikora Bulk Drug Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dikora Bulk Drug has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD4926K1ZD | Maharashtra | Active | 21 Jan 2018 |
To see the full GST registrations and return filing status of Dikora Bulk Drug Private Limited, buy the company report.
Recent activity
Dikora Bulk Drug Private Limited has 7 board changes on record since 2017: 6 appointments and 1 cessation. The latest: Ishwar Purshotam Patel ceased to be Director on 21 Oct 2019.
AGM
Dikora Bulk Drug Private Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records.
Charges
A charge registered on 04 Dec 2018 via Charge ID 100225527 with State Bank Of India was fully satisfied on 16 Jul 2025.
Filing
Dikora Bulk Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.58 Cr with Charge ID 101009720 was registered on 09 Oct 2024.
Charges
A charge with State Bank Of India of Rs. 3.88 Cr registered on 04 Dec 2018 with Charge ID 100225527 was modified on 02 Mar 2022.
Ceased
Ishwar Purshotam Patel ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 3.88 Cr with Charge ID 100225527 was registered on 04 Dec 2018.
Appointed
Dineshkumar Purushottam Patel was appointed as Director.
Appointed
Komal Vikram Patil was appointed as Director.
Appointed
Pratik Dinesh Patel was appointed as Director.
Appointed
Prema Kumar Doddamitta was appointed as Other Promoter.
Appointed
Rohit Dinesh Patel was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Dikora Bulk Drug is an active private limited company based in Bhusawal, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 28 December 2017 (9+ years old) and is registered under CIN U24100MH2017PTC303432.
Dikora Bulk Drug has 5 current directors:
- Dineshkumar Purushottam Patel - Director
- Komal Vikram Patil - Director
- Rohit Dinesh Patel - Director
- Pratik Dinesh Patel - Director
- Yogesh Purushottam Patel - Director
The latest financial statements of Dikora Bulk Drug on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Dikora Bulk Drug is 27AAGCD4926K1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dikora Bulk Drug is U24100MH2017PTC303432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dikora Bulk Drug was incorporated on 28 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dikora Bulk Drug by revenue are Mirth Capital and Finlease Limited, Chemosol Industries (India) Private Limited, Omicron Pharma Private Limited, Anika Cards N Crafts Private Limited, Enzosynth Private Limited, all in the Chemicals industry (API Manufacturers, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ishwar Purshotam Patel ceased to be Director on 21 Oct 2019. Dineshkumar Purushottam Patel was appointed as Director on 28 Dec 2017. Komal Vikram Patil was appointed as Director on 28 Dec 2017. Dikora Bulk Drug has 7 board changes on record in total.
Yes, Dikora Bulk Drug is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Dikora Bulk Drug is registered as a small enterprise under Udyam registration (number: UDYAM-MH-14-0019040).
Dikora Bulk Drug can be reached through the website dikorabulkdrug.com. Its registered office is in Bhusawal, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages